Article

Acupuncture Versus Valproic Acid In The Prophylaxis Of Migraine Without Aura: A Prospective Controlled Study.

Department of Neurosciences, University of Padua,Padova, Italy - .
Minerva anestesiologica (Impact Factor: 2.27). 03/2013;
Source: PubMed

ABSTRACT Background: The pharmacologic treatment of migraine still remains below the expectations. The aim of this study is to compare the effectiveness of traditional acupuncture and valproic acid in migraine prophylaxis. Materials and Methods: A prospective, controlled study was performed in 100 patients affected by migraine without aura lasting for over one year. The patients were stratified for sex and randomly divided into two groups of 50 patients each. Patients belonging to Group A (acupuncture) were submitted to 20 sessions of acupuncture, while patients belonging to Group V valproate) were administered Valproic acid (Depakin ChronoÒ) at a dose of 600 mg/day; 10 mg Rizatriptan wafers were allowed as needed to treat the attacks. The Midas Index (MI) and pain intensity (PI, by VAS) were recorded before treatment (T0), at three (T1) and six (T2) months; a six-point scale Pain Relief score (PRS), the Rizatriptan intake and adverse events were recorded at T1 and T2. Results: 82 out of 100 patients completed the study (9 dropouts in each group). In both groups the MI improved at T1 and T2 (p<0.0001). Pain intensity was better at T1 in group V (p<0.0001), but PI and PRS (p=0.02) as well as rizatriptan intake (p=0.001) were better in group A at T2. The rate of adverse events was 47.8% in group V and 0% in group A. Conclusions. Our data show a lower pain intensity and lower Rizatriptan intake at six-months follow-up with no adverse events in acupuncture patients compared to those treated with valproic acid.

Full-text

Available from: Alice Josephine Fauci, May 19, 2015
0 Followers
 · 
78 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Migraine is a complex and multifactorial brain disorder affecting approximately 18% of women and 5% of men in the United States, costing billions of dollars annually in direct and indirect healthcare costs and school and work absenteeism and presenteeism. Until this date, there have been no medications that were designed with the specific purpose to decrease the number of migraine attacks, which prompts a search for alternative interventions that could be valuable, such as acupuncture. Acupuncture origins from ancient China and encompasses procedures that basically involve stimulation of anatomical points of the body. This manuscript reviews large and well-designed trials of acupuncture for migraine prevention and also the effectiveness of acupuncture when tried against proven migraine preventative medications. Acupuncture seems to be at least as effective as conventional drug preventative therapy for migraine and is safe, long lasting, and cost-effective. It is a complex intervention that may prompt lifestyle changes that could be valuable in patients' recovery. © 2015 American Headache Society.
    Headache The Journal of Head and Face Pain 02/2015; 55(3). DOI:10.1111/head.12525 · 3.19 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The present study aimed to investigate the efficacy of repetitive cathodal direct current stimulation (rctDCS) over the visual cortex as a prophylactic treatment in patients with menstrual migraine. 20 female patients were recruited in this double-blind, placebo-controlled study and were assigned to receive either cathodal or sham stimulation. Over 3 menstrual cycles, tDCS with 2mA intensity and 20min duration was applied to the visual cortex of the patients, in 5 consecutive sessions 1-5days prior to the first day of their menstruation. The primary endpoint of the study was the frequency of the migraine attacks at the end of the treatment period, however, additional parameters, such as the number of migraine related days and the intensity of pain were also recorded 3months before, during and 3months post-treatment. Visual cortex excitability was determined by measuring the phosphene thresholds (PTs) using single pulse transcranial magnetic stimulation (TMS) over the visual cortex. Sixteen patients completed the study. A significant decrease in the number of migraine attacks (p=0.04) was found in the cathodal group compared to baseline but not compared to sham (p=0.053). In parallel the PTs increased significantly in this group, compared to the sham group (p<0.05). Our results indicate that prophylactic treatment with rctDCS over the visual cortex might be able to decrease the number of attacks in patients with menstrual migraine, probably by modifying cortical excitability. Copyright © 2015 Elsevier B.V. All rights reserved.
    Journal of the neurological sciences 05/2015; DOI:10.1016/j.jns.2015.05.009 · 2.26 Impact Factor